Clinical Trials Network Award
- The Clinical Trials Network Award will be made to an institution, organization, or physician group with an established clinical trials infrastructure and clinical trials portfolio to develop and oversee a network of two cancer care facilities that lack adequate access to clinical trials or sufficient clinical trials infrastructure (stage 1). Once an initial network is satisfactorily demonstrated, the program will be eligible to expand its network to two additional facilities located outside its current catchment (stage 2). Award: Up to $600,000 annually for stage 1 and up to $900,000, annually for stage 2. Maximum duration: 4 years.
Core Facilities Support Awards
- Solicits applications from institutions to establish or enhance core facilities (laboratory, clinical, population-based, or computer-based) that will directly support cancer research programs to advance knowledge of the causes, prevention, and/or treatment of cancer or improve quality of life for patients with and survivors of cancer. Institutions may submit 2 applications provided that 1 exclusively supports childhood cancer research. Award: Up to $4,000,000 (total costs); Maximum duration: 5 years.
Early Clinical Investigator Award
- Solicits applications from institutions to provide cancer physicians within the first 3 years of a faculty appointment as an assistant professor the opportunity to develop clinical research skills and to gain experience in advanced methods and experimental approaches needed to become successful clinical investigators. The award will protect time from clinical responsibilities to allow the early clinical investigator to develop and conduct investigator initiated clinical trials and to establish a partnership with a laboratory-based collaborator in order to design and conduct correlative studies needed to interpret the outcome of an interventional trial. The overall goal of this mechanism is to increase the pool of clinical investigators at Texas academic institutions who are conducting patient-oriented studies, capitalizing on basic discoveries and translating them through conduct of innovative clinical trials involving cancer patients or individuals at risk for cancer. Institutions may submit up to 2 applications. Award: Up to $1,500,000 (total costs); Maximum duration: 5 years.
High-Impact/High-Risk Research Awards
- Provides short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancers. Institutions may submit up to 5 applications. Award: Up to $250,000 (total costs); Maximum duration: 2 years.
Texas Regional Excellence in Cancer Award
- Solicits applications to strengthen cancer research at institutions located in regions of Texas that have historically received low levels of peer reviewed cancer research funding. This mechanism is open to Texas institutions whose campus is located > 100 mi from an NCI Designated Cancer Center. The award will support an established investigator to lead a program with a cohesive theme relevant to the cancer problems of the region and 3 to 5 research projects. In addition, funds maybe requested to support recruitment of new junior faculty, shared resources, and partnerships with established Texas cancer research programs to provide mentorship and access to facilities or expertise. Award: Up to $6,000,000 (total costs); Maximum duration: 5 years.